Cargando…

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shunjie, Ren, Xiaotong, Li, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295421/
https://www.ncbi.nlm.nih.gov/pubmed/35854339
http://dx.doi.org/10.1186/s40164-022-00296-9
_version_ 1784750054889750528
author Yu, Shunjie
Ren, Xiaotong
Li, Lijuan
author_facet Yu, Shunjie
Ren, Xiaotong
Li, Lijuan
author_sort Yu, Shunjie
collection PubMed
description Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. In malignant tumors, MDSCs, one of the most dominant cellular components comprising the tumor microenvironment, play a crucial role in tumor growth, drug resistance, recurrence, and immune escape. Although the role of MDSCs in solid tumors is currently being extensively studied, little is known about their role in hematologic malignancies. In this review, we comprehensively summarized and reviewed the different roles of MDSCs in hematologic malignancies and hematopoietic stem cell transplantation, and finally discussed current targeted therapeutic strategies.Affiliation: Kindly check and confirm the processed affiliations are correct. Amend if any.correct
format Online
Article
Text
id pubmed-9295421
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92954212022-07-20 Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin Yu, Shunjie Ren, Xiaotong Li, Lijuan Exp Hematol Oncol Review Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. In malignant tumors, MDSCs, one of the most dominant cellular components comprising the tumor microenvironment, play a crucial role in tumor growth, drug resistance, recurrence, and immune escape. Although the role of MDSCs in solid tumors is currently being extensively studied, little is known about their role in hematologic malignancies. In this review, we comprehensively summarized and reviewed the different roles of MDSCs in hematologic malignancies and hematopoietic stem cell transplantation, and finally discussed current targeted therapeutic strategies.Affiliation: Kindly check and confirm the processed affiliations are correct. Amend if any.correct BioMed Central 2022-07-19 /pmc/articles/PMC9295421/ /pubmed/35854339 http://dx.doi.org/10.1186/s40164-022-00296-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Yu, Shunjie
Ren, Xiaotong
Li, Lijuan
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
title Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
title_full Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
title_fullStr Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
title_full_unstemmed Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
title_short Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
title_sort myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295421/
https://www.ncbi.nlm.nih.gov/pubmed/35854339
http://dx.doi.org/10.1186/s40164-022-00296-9
work_keys_str_mv AT yushunjie myeloidderivedsuppressorcellsinhematologicmalignanciestwosidesofthesamecoin
AT renxiaotong myeloidderivedsuppressorcellsinhematologicmalignanciestwosidesofthesamecoin
AT lilijuan myeloidderivedsuppressorcellsinhematologicmalignanciestwosidesofthesamecoin